Lymphadenopathy: Evaluation and Differential Diagnosis.
Falk N, Joseph R, Dieujuste M.
Am Fam Physician. 2025 Sep;112(3):286-293.
Clinical manifestations of HIV infection, including persistent generalized lymphadenopathy and AIDS-related complex.
Abrams DI.
J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1217-22. doi: 10.1016/0190-9622(90)70166-f.
Persistent, generalized lymphadenopathy among homosexual males.
Centers for Disease Control (CDC).
MMWR Morb Mortal Wkly Rep. 1982 May 21;31(19):249-51.
Immunohistopathogenesis of persistent generalized lymphadenopathy in HIV-positive patients.
Baroni CD, Vitolo D, Uccini S.
Ric Clin Lab. 1990 Jan-Mar;20(1):1-10. doi: 10.1007/BF02910143.
Canakinumab (Ilaris) [Internet].
[No authors listed]
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.
Epstein-Barr virus and its association with disease - a review of relevance to general practice.
Fugl A, Andersen CL.
BMC Fam Pract. 2019 May 14;20(1):62. doi: 10.1186/s12875-019-0954-3.
Lymph nodes in HIV-positive drug abusers with persistent generalized lymphadenopathy: histology, immunohistochemistry, and pathogenetic correlations.
Baroni CD, Uccini S.
Prog AIDS Pathol. 1990;2:33-50.
The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy.
Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P.
Can Med Assoc J. 1985 Jun 1;132(11):1273-9.
Persistent and generalized lymphadenopathy: a lesion of follicular dendritic cells? An immunohistologic and ultrastructural study.
Piris MA, Rivas C, Morente M, Rubio C, Martin C, Olivia H.
Am J Clin Pathol. 1987 Jun;87(6):716-24. doi: 10.1093/ajcp/87.6.716.
Persistent generalized lymphadenopathy: immunological and mycological investigations.
Torssander J, Wasserman J, Morfeldt-Månsson L, Petrini B, von Stedingk LV.
Acta Derm Venereol. 1985;65(6):515-20.
